drugset / Trial / NCT06251076
Plan Development for Giving Teclistamab in the Outpatient Setting
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a pilot study to develop an outpatient-based process for the administration of teclistamab for for relapsed/refractory multiple myeloma patients and to evaluate the burden on caregivers of patients receiving outpatient administration of teclistamab.
Timeline
- Start
- 2024-11-19
- Primary completion
- 2026-06-15
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teclistamab | Monoclonal antibody | — | — |
| Subject | Tocilizumab | Monoclonal antibody | — | — |